戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 han that elicited by the negative control to any of 10 inhalant or food allergens.
2 duced ejection fraction and were enrolled in any of 12 clinical trials spanning the period from 1995
3 me biogenesis due to bi-allelic mutations in any of 13 different PEX genes.
4 assessed were not eligible for enrollment in any of 15 major randomized controlled trials in critical
5              Accordingly, the exact role, if any, of (18)F-FLT PET in NENs remains to be established.
6 ants reported whether they were experiencing any of 21 common antipsychotic side effects, vital signs
7 s between 2007 and 2011 and were admitted to any of 2217 dialysis facilities in 43 states operated by
8 ited patients aged 14-35 years presenting to any of 35 mental health services sites across England wi
9 ees with a new, adjudicated prescription for any of 38 oral anticancer agents.
10 ng to an employment model and improvement in any of 4 primary composite quality metrics.
11 cant differences in the associations between any of 9 available classes of glucose-lowering drugs (al
12 in which IgE antibodies are produced against any of a broad variety of apparently harmless antigens.
13     The gradual accumulation of mutations by any of a number of mutational processes is a major drivi
14  Recon outputs accurate, robust estimates by any of a vast set of complementary diversity measures, i
15 ntre of a vigorous debate about the role, if any, of arboreal locomotion in early human evolution.
16                   Severe disability included any of Bayley Scales of Infant Development III cognitive
17 illion people become infected every day with any of four curable sexually transmitted infections (STI
18 dense granule biogenesis due to mutations in any of >/=9 different genes.
19 an incident HBV infection as the presence of any of HBV serological markers (hepatitis B surface anti
20 limiting our understanding of the effect (if any) of inflammatory biomarkers on schizophrenia risk.
21          Conjugation of SAN1 did not disrupt any of its antiangiogenic or cytotoxic properties in GnR
22      Publications dealing with sorafenib and any of its common adverse effects were considered; this
23 XL, IC50 = 158 muM; CVX, IC50 = 11 muM) than any of its enantiomers S (6c) (collagen, IC50 = 25.3 muM
24 y risen with the discovery that mutations in any of its four subunits cause a form of hereditary spas
25 le node overrides that steer a system toward any of its natural long-term dynamic behaviors, regardle
26  be extensively m(6)A modified, the role, if any, of m(6)A in regulating viral gene expression and re
27 rimary outcome was patient-level exposure to any of nine measures of high-risk prescribing of nonster
28 e, stroke, respiratory disease, or cancer in any of our analyses.
29  were unable to acquire the GDM phenotype in any of our experiments, and we recommend researchers do
30 of this chemical series was more active than any of our previous inhibitors with a Ki of 1.0 nM.
31 found no associations between inbreeding and any of our six fitness measurements.
32  can be compared by 'virtual integration' to any of PATRIC's public data.
33 lusively detected by HMZDelFinder and not by any of seven other CNV detection tools examined.
34 ry CT angiography (FFRCT) data sets by using any of several advanced computational analytic approache
35     Similar systems could be destabilized by any of several mechanisms, contributing to the observed
36  alleles were produced either by deletion of any of single PASTA domain or by mutation of individual
37 ama and is not significantly associated with any of the > 500 species in a regional network of forest
38  virus patients who were treated with DAA in any of the 129 Veterans Health Administration hospitals
39  any of the other individual outcomes or for any of the 14 summary indices were not significant.
40 tly associated with levels of IE adhesion to any of the 19 receptors.
41 s increased activity was not achievable with any of the 20 proteogenic amino acids.
42 -ir fiber fractional areas or cell bodies in any of the 22 subregions of the forebrain SBNN.
43 , or infant mortality, neither overall or in any of the 26 examined subgroups.
44 e designed to achieve selective knockdown of any of the 3 CALM genes, making it a generalizable thera
45 n several single-nucleotide polymorphisms in any of the 3 epochs and adult BP-related single-nucleoti
46  use among 12th graders in Washington or for any of the 3 grades in Colorado.
47 dard PET-based diagnosis was not affected by any of the 3 MR-AC methods.
48 nterval duration (QTc) nor cardiac events in any of the 3 mutation groups.
49  Conversely, no correlation was seen, during any of the 3 time periods, with either homicide or Black
50                               Infection with any of the 4 dengue virus serotypes results in a diverse
51 e of recent prior infection were observed in any of the 4 patient contacts identified.
52                               Infection with any of the 4 related dengue virus serotypes (DENV-1-4) i
53 d for their exclusive intake or no intake of any of the 4 same foods.A total of 249 mass spectrometri
54  prevent DS TB-related catastrophic costs in any of the 6 countries, and when increased enough to pre
55 inical tumor lysis syndrome did not occur in any of the 60 patients in the expansion cohort.
56 lysis bore no evidence of virus evolution in any of the 8 children with viremia suppression on ART.
57 ciation between the achieved LDL-C level and any of the 9 prespecified safety events.
58  Among females, seroprevalence was 40.5% for any of the 9 vaccine types, 30.0% for any 7 HR types (16
59           In KTR with positive serostatus to any of the above viruses, SRL + MPA or SRL + Tac was not
60 parable with laparoscopic Heller myotomy for any of the achalasia syndromes; and 5) post-POEM patient
61 ot modulate methacholine-induced sweating at any of the administered concentrations.
62 gnificantly decrease ammonium adsorption for any of the adsorbents.
63  reporting moderate or greater difficulty in any of the aforementioned tasks.
64             TPA release was not augmented by any of the agonists tested but urokinase was released by
65                 There were no differences in any of the analytes in participants randomized to the ex
66     GNA11 mutations were not associated with any of the analyzed features.
67                      DON was not detected in any of the analyzed samples whereas FB1 was found in 49%
68 There was no tumor location predilection for any of the assessed molecular parameters (permutation-ad
69            Greenness was not associated with any of the asthma trajectories.
70                                      Loss of any of the ATG genes, except FgATG17, prevented the fung
71 s, with currently no female heads of unit in any of the Australian and New Zealand transplanting cent
72 show morphological/anatomical alterations in any of the axonal populations and parameters analyzed.
73         With a pre-existing chiral center at any of the backbone sp(3)-carbons, the reaction remained
74 ontroversial and has not been determined for any of the bacterial enzymes that are exploited as model
75                              In fact, should any of the biomarkers be nonexistent, the signal remains
76 ophrenia patients and comparison subjects in any of the brain regions studied (thalamus, caudate, put
77         Treatment modality did not influence any of the cardiovascular responses to dialysis.
78  all the Cch-evoked responses did not affect any of the CCK-8-evoked responses, indicating that rathe
79  found no evidence of a beneficial effect on any of the clinical manifestations or on dengue viremia.
80  genes, mcr-1 and mcr-2 were not detected in any of the ColR CRKp.
81  correlation with the FISH measurements than any of the comparison methods.
82  placebo to reduce mortality, and no ORs for any of the comparisons versus placebo were significant.
83               However, it is unknown whether any of the components within the QT interval are respons
84 on of fibril formation was not complete with any of the compounds.
85 antly, KYNA levels did not alter lifespan in any of the conditions tested.
86 he cavities, which grow perpendicularly onto any of the conducting surface.
87 healthy controls with no deficit observed in any of the control tasks.
88 enetically-inherited pathogenic mutations in any of the core autophagy-related (ATG) genes have been
89 sitemia did not differ by treatment group at any of the cross-sectional surveys.
90 ither cyanidin nor delphinidin were found in any of the cultivars.
91 al that Spanish teosinte does not group with any of the currently recognized teosinte taxa.
92                                       Having any of the CVRFs increased the risk of CVD in cancer sur
93                                Disruption of any of the direct substrate-protein residue interactions
94 usted without changing the peptide length or any of the directly interacting residues.
95 kemia (BCP-ALL) could not be classified into any of the established molecular subtypes.
96                                           If any of the EV-associated proteins identified were to be
97 ess between whitefish of different origin in any of the evaluated characteristics.
98 cies to the same risk categories and whether any of the existing methodologies perform well at identi
99 he new predictor has remarkably outperformed any of the existing methods for the same purpose on ROC5
100                 The assays can be applied to any of the existing mouse models for retinal disorders a
101 3) and NICU admission (P = .02) but not with any of the factors examined.
102 no significant treatment difference noted in any of the falsification end-point rates when analyses w
103                   A lesion not detectable on any of the follow-up images was considered a completely
104                          Complex lesions had any of the following characteristics: unprotected left m
105 lity and (2) time to the first occurrence of any of the following events: cardiac death, ischemic str
106  a composite of treatment failure defined by any of the following occurring within 7 days of enrollme
107 nital defects in pregnant women treated with any of the following: 1) a vitamin K antagonist (VKA) th
108 ithin the previous 36 h, active dyspnea, and any of the following: 1) estimated glomerular filtration
109 ve patients (n = 943) were defined as having any of the following: a kidney biopsy with PV associated
110 ad no history of atrial fibrillation but had any of the following: CHA2DS2-VASc score of >/=2, sleep
111               MET-driven PRCC was defined as any of the following: chromosome 7 copy gain, focal MET
112 ration was significantly reduced by blocking any of the following: Fcgamma receptor binding (P = 0.04
113 y composite measure of HI-EOL care comprised any of the following: intravenous chemotherapy < 14 days
114 al impairment was defined as the presence of any of the following: moderate to severe cerebral palsy,
115 rimary end point was the first occurrence of any of the following: new diagnosis of coronary artery d
116 d as mortality or major morbidity, including any of the following: persistent periventricular echogen
117 iochemical-clinical failure (BCF) defined by any of the following: PSA failure (nadir + 2), hormonal
118 pecific in populations previously exposed to any of the four dengue viruses or West Nile virus, or va
119              No evidence of LGR5 coupling to any of the four major subtypes of heterotrimeric G prote
120 ed syngeneic model of ovarian cancer, lacked any of the frequent mutations in HGSC, and used CRISPR/C
121 varioles, or ovipostioning were seen between any of the generations tested.
122  However, these patients lacked mutations in any of the genes previously associated with WAS.
123 the mouse genome did not alter expression of any of the genes.
124 holic, and non-Catholic private schools with any of the grades from kindergarten through 12 were elig
125 HF receiving towers, we found no evidence in any of the groups for compensatory directional response
126                   There was no difference in any of the groups in time to culture conversion on solid
127 ity or significant morbidity was observed in any of the groups.
128             Furthermore, it can be used with any of the growing number of fluorescent ABPs to provide
129  or between EC users and control subjects in any of the health outcomes investigated.
130  are also susceptible to bias that arises in any of the included primary studies, each of which needs
131 c biological functions have been ascribed to any of the individual c-di-GMP synthases or phosphodiest
132 later.Sedentary time was not associated with any of the individual cardiometabolic risk factors or cl
133  that produces a disease state not seen with any of the individual species alone.
134 meta-predictor has improved performance over any of the individual tools.
135 oil C loss was not significantly affected by any of the interactions, although it was constrained by
136 ction or depressive symptoms at 12 months in any of the intervention groups compared with usual care.
137 er the last 100 years have been colonized by any of the invaders investigated, despite offering clima
138 ort a strong biological link between HCC and any of the investigated psychological variables.
139                                          For any of the ISs studied there is no region of the circula
140 (V8-V9) of the OTUs could not be assigned to any of the known eukaryotic groups.
141 of Ca. P. anaerolimi, but it appears to lack any of the known natural carbon fixation pathways.
142 , and show that it does not bind directly to any of the known netrin-1 receptors.
143 contact angles with consistent accuracy when any of the liquids in consideration has a capillary leng
144 d to predict the likelihood of a mutation in any of the LS genes by using polytomous logistic regress
145 d; however, there was no association between any of the markers and subsequent stunting.
146  should not reach the melting temperature of any of the matched hybrids.
147 n of saccharin before the OGTT did not alter any of the measured variables but eliminated the effects
148 turally diverse proteins or pathways mediate any of the medical benefits of manassantin in vivo Moreo
149 d lines in maternal FM in late pregnancy for any of the methods.
150 r needle, no adverse events were observed in any of the mice used in the study.
151 mode that provide fatty acyl information for any of the modified lipids.
152 nctions at higher levels simultaneously than any of the monocultures (i.e., >67th percentile).
153 loser to optimizing all three functions than any of the monocultures.
154                                In principle, any of the multiple causes of clinical stroke can cause
155 and six pariah groups which do not belong to any of the natural families, and are not involved in the
156                                     Changing any of the network parameters (within the parameter spac
157 n breakfast meal consumption and fasting for any of the neuropsychological measures administered.
158 ted array measurements but were not found in any of the NGS experiments of the same individual.
159 the emm32.2 iGAS isolates but not present in any of the non-emm32.2 control isolates.
160                   There was no evidence that any of the nonnative rDNA units were transcribed; some s
161 of these ARs in the quinoa plant and whether any of the novel ARs may be of particular interest in hu
162 loss of E-cadherin and occludin, mutation of any of the NPF domains of GFP-FIP2(S227E) reestablished
163 Current Procedural Terminology codes matched any of the operations identified as a high-risk vascular
164 tions in balance of excitation/inhibition in any of the other auditory brainstem nuclei measured, sug
165 not verify any causal effect of CRP level on any of the other common somatic and neuropsychiatric out
166     No significant differences were found in any of the other comparisons in underpowered RCT data.
167 , 1.06-1.34) was associated with SCD and not any of the other components in separate models.
168                                  Effects for any of the other individual outcomes or for any of the 1
169 more consistent to recombinant beta2 than to any of the other isoforms, making this protein a potenti
170  it provide sustained benefit with regard to any of the other measured outcomes.
171 e same conditions, it does not interact with any of the other members of the contactin family.
172 es, either for all serious adverse events or any of the other nine prespecified safety events.
173 ut was not associated with increased risk of any of the other secondary outcomes.
174 ically significant differences were seen for any of the other secondary outcomes.
175  observed between IVT and MT vs MT alone for any of the outcomes.
176                            We tested whether any of the oxidative stress-related hormones could induc
177 d-Bishop-Dauxois model and, without changing any of the parameters of the two models, apply this new
178  chimeras express at even higher levels than any of the parents.
179 uene oxidation but they do not seem to favor any of the pathways.
180            Anti-ETN Abs were not detected in any of the patient samples tested.
181 catalytically inactive mutant did not elicit any of the phenotypes, which confirms abnormal peptide h
182 ypic methods, </=43% were serogroupable with any of the phenotypic methods tested.
183 o evidence of heterogeneity was observed for any of the pre-specified subgroup analyses.
184           LPS-free OVA does not recapitulate any of the precursor signs of AD, supporting a triggerin
185 ea 5 is as direct and prominent as that from any of the premotor areas in the frontal lobe.
186 lity [Formula: see text]) faster than during any of the previous 27 centuries.
187 with superior sensitivity and flexibility to any of the previously commercially available alternative
188  electron-richness, they are not amenable to any of the previously developed N-protection strategies
189 ignificant changes in the odds of developing any of the primary outcomes.
190 n the investigator's choice group) completed any of the PRO questionnaires at baseline and at least o
191 of therapy had no significant differences in any of the PROs.
192 roups, and there were no differences between any of the PS (PS-C and PS-CP), and PsA (PsA-C and PsA-C
193 of tumors larger than or equal to 0.5 mL for any of the readers of the short MR imaging protocol, wit
194 tal and Trauma Center (the highest number at any of the receiving medical facilities; age range, 4-74
195  statistically significant relationship with any of the renal outcomes.
196               CLEC2 depletion did not affect any of the responses during pneumonia.
197 did not demonstrate a significant benefit of any of the restrictions regarding food, social contacts,
198 re are no empirical data to demonstrate that any of the reviewed strategies provide a greater net ben
199 shment are unknown and it is unclear whether any of the RhopH proteins play a role in invasion.
200 ell-tolerated, demonstrating no elevation in any of the safety parameters evaluated.
201 exposed rats (N = 8) and was not detected in any of the saline treated animals (N = 6).
202 of the selected metabolites were detected in any of the samples.
203 ically significant differences in changes in any of the scales of quality of life from baseline to ch
204 alp electroencephalograms failed to identify any of the scalp-negative seizures.
205 confirmatory testing by IEF, without missing any of the SCD newborns in the studied cohort.
206 d therapy also did not significantly improve any of the secondary end points.
207 as observed regarding sex for the primary or any of the secondary end points.
208 s needed to determine whether the effects on any of the secondary outcomes are statistically signific
209  have a significant adverse association with any of the secondary outcomes, such as the likelihood of
210 xis, PET did not differ from prophylaxis for any of the selected outcomes, but was rather associated
211 is, which can be caused by intoxication with any of the seven known serotypes of botulinum neurotoxin
212 ndonucleolytic pathway that does not involve any of the six 3' --> 5' exonucleases (RNase T, RNase PH
213 covery of the transcripts examined, nor were any of the six excess light-associated methylome changes
214 e: January 1, 2014, to December 31, 2014) in any of the six specified community ICUs were included in
215 did not significantly relate to the level of any of the solutes measured.
216 determine if R-loops have a direct effect on any of the steps involved in isotype switching, we gener
217 action rates by decreasing the koff rates of any of the steroids.
218 interactions between the aortic diameter and any of the stratified variables were found (all p > 0.05
219 mechanism at low ionic strengths </=5 mM for any of the studied particles.
220                   No deaths were reported in any of the study groups and most reported adverse events
221 ed treatment in the overall population or in any of the subgroups, with the possible exception of pat
222 dup of a range of pyrrole derivatives, where any of the substituents can be independently varied.
223 d Hof1) are able to interact physically with any of the subunits in the septin collar and, if so, wit
224 ignificantly associated with the adoption of any of the sun safety school practices studied (eg, metr
225 ncrease in apoptosis or necrosis observed in any of the tested cell lines.
226 s did not have significant associations with any of the tested ILs.
227 and it did not affect control performance in any of the tests.
228 ve at defending against invaders targeted by any of the three CRISPR-Cas systems.
229  in cat2 dhar1 dhar2 dhar3 complemented with any of the three DHARs.
230   The present study further establishes that any of the three double-ring building blocks of zeolites
231 ferences in 3-year cognitive decline between any of the three intervention groups and the placebo gro
232 experiments, SMG-1 does not appear to act in any of the three major pathways known to mend DNA DSBs,
233              Although most E2s can work with any of the three mechanistically distinct classes of E3s
234                                  Mutation of any of the three NPF domains within GFP-FIP2(S227E) resc
235     We were not able to detect ILC1 cells in any of the tissues assessed, however, we identified intr
236 etween donor age and degree of scrolling for any of the tissues tested was found.
237 ce of heterogeneity in treatment effect (for any of the treatments) across prespecified subsets.
238  of pregnancy was not the primary outcome in any of the trials.
239                 Site-directed mutagenesis of any of the two conserved catalytic glutamic acid residue
240   Participants were slower when categorizing any of the two emotions as long as it was congruent with
241 There was no significant correlation between any of the two measures of rod-mediated dark adaptation
242 e metabolite profile could be identified for any of the types.
243 ial DNA haplogroups were not associated with any of the variables.
244 ween the high-DHA and standard-DHA groups in any of the visual-processing measures.
245 mbitious maritime dispersal of humans across any of the world's seas or oceans.
246 d few cells of any kind and less than 2%, if any, of the total newly proliferated and molecularly con
247 onversion to an employment relationship with any of their privileged physicians.
248 or the membrane is increased with respect to any of them acting in isolation, as revealed by isotherm
249 proposed, but establishing firm evidence for any of them has proved elusive.
250 ] cycloaddition, and it remains uncertain if any of them proceed via the Diels-Alder mechanism.
251 rmine whether the early expression levels of any of these 16 genes are predictive for post-stroke blo
252 e alone </=0.5 mM had little to no effect in any of these assays.
253 sites completely failed to support fusion in any of these assays.
254 edge, this study is the first to demonstrate any of these association signals in any African populati
255  factor in multiple disorders, could explain any of these associations.
256 f 518 patients) did not qualitatively change any of these associations.
257            We found that 1 Hz stimulation of any of these cell types reduced the frequency and durati
258                Activation of conductances in any of these cells affects the excitability of the syncy
259  taken before immunization failed to develop any of these changes.
260 plasty procedure/stent (1.35; 1.08-1.69), or any of these CHD end points combined (1.62; 1.39-1.89),
261  differences were found among treatments for any of these counts at any time point.
262 ns from donors who were later diagnosed with any of these diseases versus patients who received blood
263 age' network (lower blocks) does not capture any of these dynamics.
264 t free admissions as those without record of any of these events.
265 ough risk was negligible in patients without any of these factors, their addition progressively incre
266 at copies of cp-ndh genes are not present in any of these four nuclear genomes.
267                        It is unclear whether any of these genes, other than dopamine receptor D2, are
268 tify a new panel of GPCs, and tested whether any of these GPCs are associated, in adolescence, with c
269                             Small changes in any of these in appropriate narrow ranges switches the r
270 sians, and we can reject the hypothesis that any of these individuals had substantial Native American
271 , and hypoblast are interchangeable to begin any of these inductions while the final outcome depends
272   Targeting MAP4K4, MINK1, and TNIK, but not any of these kinases individually, is sufficient to prot
273 hat the connectivity was not consistent with any of these main topological classes.
274 ation of oo18 RNA-binding proteins (ORBs) in any of these MBONs impaired LTM.
275    However, there is limited data to support any of these mechanisms as important in driving T cell a
276 ct the community composition or diversity of any of these microbial groups; however, microbial commun
277 ivisions or physical compartmentalization in any of these microscopic brains.
278 , direct experimental evidence in support of any of these models is limited and a firm conclusion is
279                                 Insertion of any of these motifs into the complementarity-determining
280          The viral molecular determinants of any of these phenotypes are not well understood.
281                                              Any of these polymers featured a significant thermal res
282                              Perturbation of any of these processes could cause cleft palate, a commo
283 ission rates, but DOA feeding did not affect any of these processes except at very high application c
284 cles, nor octameric core histones reproduced any of these procoagulant effects.
285                                  Mutation at any of these residues significantly diminished the inter
286                            Thus, mutation of any of these residues to Ala abrogated zinc transfer fro
287 melanoma who were at lower risk (ie, without any of these risk factors), the higher-risk group had a
288                Mutations aimed at disrupting any of these salt bridges activated binding unless the m
289 elix-turn-helix motifs, and mutations within any of these severely compromise biological activity.
290                                  The lack of any of these signals ameliorates malarial anaemia during
291 ax meningitis was unlikely in the absence of any of these signs or symptoms (likelihood ratio [LR]- =
292                                  Blockade of any of these steps causes hyperproliferation and loss of
293                                              Any of these strategies may help to remedy some of the m
294 ng effects on the brain than a single use of any of these substances.
295 o far in the literature and try to assess if any of these techniques should be treated as a leading m
296                                              Any of these three limitations are able to adequately de
297 ility of relevant vector species to transmit any of these viruses (that is, their vector competence)
298                                          For any of these, it is essential to design surfaces that en
299 ons in new discoveries correctly detected by any of three methods (SETH, tmVar, or nala ).
300  IDREAM consistently outperformed PROM using any of three popular yeast metabolic models and across t

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top